Deutsche Bank Upgrades Johnson & Johnson (JNJ) to Buy; Well-Diversified and Positioned

January 4, 2013 7:27 AM EST Send to a Friend
Get Alerts JNJ Hot Sheet
Price: $100.30 +0.12%

Rating Summary:
    7 Buy, 12 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 10 | New: 20
Trade JNJ Now!
Join SI Premium – FREE
Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from Hold to Buy with a price target of $82.00 (from $75.00).

The firm comments, "For the past several years, JNJ has weathered through patent expirations, a general slowdown in utilization trends, and challenges with its OTC businesses. As we look ahead to 2013, we believe JNJ will see improving trends. We expect recent and new drugs to continue to drive pharma sales. A slight improvement in utilization and new products should benefit MD&D. For Consumer, J&J should continue to work through the McNeil Consent Decree and return products to market. Given these improving trends and the benefits of diversification, we believe JNJ deserves a premium to its peers."

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

Shares of Johnson & Johnson closed at $70.74 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Deutsche Bank

Add Your Comment